The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin
Open Access
- 14 June 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 4 (6) , 760-767
Abstract
Tumors are phenotypically heterogeneous and include subpopulations of cancer cells with stemlike properties. The natural product salinomycin, a K+-selective ionophore, was recently found to exert selectivity against such cancer stem cells. This selective effect is thought to be due to inhibition of the Wnt signaling pathway, but the mechanistic basis remains unclear. Here, we develop a functionally competent fluorescent conjugate of salinomycin to investigate the molecular mechanism of this compound. By subcellular imaging, we demonstrate a rapid cellular uptake of the conjugate and accumulation in the endoplasmic reticulum (ER). This localization is connected to induction of Ca2+ release from the ER into the cytosol. Depletion of Ca2+ from the ER induces the unfolded protein response as shown by global mRNA analysis and Western blot analysis of proteins in the pathway. In particular, salinomycin-induced ER Ca2+ depletion up-regulates C/EBP homologous protein (CHOP), which inhibits Wnt signaling by down-regulating β-catenin. The increased cytosolic Ca2+ also activates protein kinase C, which has been shown to inhibit Wnt signaling. These results reveal that salinomycin acts in the ER membrane of breast cancer cells to cause enhanced Ca2+ release into the cytosol, presumably by mediating a counter-flux of K+ ions. The clarified mechanistic picture highlights the importance of ion fluxes in the ER as an entry to inducing phenotypic effects and should facilitate rational development of cancer treatments.Keywords
Funding Information
- Royal Swedish Academy of Sciences
- Crafoordska Stiftelsen
- Cancerfonden
- Kungliga Fysiografiska S?llskapet i Lund
- Mrs Berta Kamprad Foundation
- Percy Falk Foundation
- NanoLund
This publication has 51 references indexed in Scilit:
- Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In VivoPLOS ONE, 2012
- Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen SpeciesPLOS ONE, 2012
- Distribution of Genes and Repetitive Elements in theDiabrotica virgifera virgiferaGenome Estimated Using BAC SequencingJournal of Biomedicine and Biotechnology, 2012
- Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cellsProceedings of the National Academy of Sciences, 2011
- Salinomycin induces calpain and cytochrome c-mediated neuronal cell deathCell Death & Disease, 2011
- Selective activation of the transcription factor ATF6 mediates endoplasmic reticulum proliferation triggered by a membrane proteinProceedings of the National Academy of Sciences, 2011
- Endoplasmic-Reticulum Calcium Depletion and DiseaseCold Spring Harbor Perspectives in Biology, 2011
- Spiperone enhances intracellular calcium level and inhibits the Wnt signaling pathwayBMC Pharmacology, 2009
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003